Back

New strategies for anticoagulation therapy after LAA closure

19 March 2018 (17:42 - 18:00)
Organised by:
Congress Presentation Part of: Novel insights of LAA treatment for atrial fibrillation and stroke prevention Stroke – Clinical EHRA Premium Access EHRA 2018

About the speaker

Photo
Professor Michael Glikson

Shaare Zedek Medical Center, Jerusalem (Israel)

5 More presentations in this session

Presentation thumbnail
This session is supported by Abbott and Boston Scientific in the form of an educational grant. The scientific programme has not been influenced in any way by these sponsors.
Slides Video
Presentation thumbnail
Stroke prevention or bleeding: how to weigh the results of clinical trials
Professor L. Boersma (Nieuwegein, NL)
Slides Video
Presentation thumbnail
The role of the LAA for AF and stroke: fact or fiction
Professor T. Lewalter (Munich, DE)
Slides Video
Presentation thumbnail
LAA closure concomitant to AF ablation - The surgical perspective
Associate Professor S. Salzberg (Zurich, CH)
Slides Video
Presentation thumbnail
LAA closure concomitant to AF ablation - The EP perspective
Professor C. Tondo (Milano, IT)
Slides Video

Access the full session

Session thumbnail
Novel insights of LAA treatment for atrial fibrillation and stroke prevention

The Event

Event poster

EHRA 2018

19 March 2018 17:42 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial appendage closure: who should get it and how to manage patients medically before, during and after?
27 August 2023
thumbnail
Congress Session
EHRA honorary lectures
31 March 2025
thumbnail
Congress Presentation
Single versus dual antiplatelet therapy following transcatheter left atrial appendage closure
4 April 2022
thumbnail
Congress Presentation
Left atrial appendage closure in patients with cancer
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources